REGULATORY RADAR

The PharmaSource Regulatory Radar tracks the policies changing where and how drugs are made, from US tariffs and EU supply rules to China’s export controls and India’s manufacturing incentives.

Every policy is scored for its impact on biopharma manufacturing and outsourcing, and the radar is updated weekly.

Access to the tracker is free, simply fill out the form.

What it covers

  • 39 policies, five regions: North America, Europe, China, South Asia and the rest of the world.
  • One score per policy: impact, reach and likelihood combine into a single ranking, so you see which rules matter most.
  • Timing at a glance: each policy’s ring shows whether it is in force or takes effect within 6, 18 or more months.
  • Five themes: protectionism, pricing and reimbursement, security and decoupling, regulation and quality, and sustainability and ESG.
  • Weekly updates: a change log records what moved and why.
  • Policy explainers: a growing library of PharmaSource briefings on what each policy does, where it stands and what it means for manufacturers, CDMOs and sponsors.

How we score: PharmaSource editors rate each policy from 1 to 10 for impact, reach and likelihood, using public sources and the scales set out in the radar. The scores are editorial judgments, reviewed as policies change.

Access the radar

Regulatory Briefings